ISSN: 1466-4100
Currently published as: Clinical Governance: An International Journal
Incorporates: Clinical Performance and Quality Healthcare
Online from: 1996
Subject Area: Health Care Management/Healthcare
Content: Latest Issue |
Latest Issue RSS | Previous Issues
Options: To add Favourites and Table of Contents Alerts please take a Emerald profile
| Title: | A multi-district model for the management of disease-modifying treatments in multiple sclerosis |
|---|---|
| Author(s): | Helen L. Ford, (Consultant Neurologist, Department of Neurology, St James’s University Hospital, Leeds, UK), Michael Johnson, (Consultant Neurologist, Department of Neurology, St James’s University Hospital, Leeds, UK), Jon Fear, (Consultant in Public Health Medicine, Leeds Health Authority, Duncombe Street, Leeds, UK) |
| Citation: | Helen L. Ford, Michael Johnson, Jon Fear, (2002) "A multi-district model for the management of disease-modifying treatments in multiple sclerosis", British Journal of Clinical Governance, Vol. 7 Iss: 4, pp.267 - 272 |
| Keywords: | Co-operation, Disease, Health care, Modelling, National Health Service, Regulations |
| Article type: | Case study |
| DOI: | 10.1108/14664100210446650 (Permanent URL) |
| Publisher: | MCB UP Ltd |
| Abstract: | This paper’s objective is to develop a model for the appropriate and equitable use of disease-modifying treatments in multiple sclerosis. The prevalence and incidence of multiple sclerosis was established in Leeds. A specialist multiple sclerosis team with two consultant neurologists and a multiple sclerosis support nurse was based at one centre. The team co-operated with purchasers to develop a model of care. This included a referral protocol, strict prescribing criteria, counselling and education of patients, the use of patient-centred outcome measures and training and feedback to other neurologists. A total of 217 people with multiple sclerosis were assessed from April 1997 to March 2000. Our experience suggests that a centralised multi-district clinic developed by close collaboration between clinicians and health purchasers and operating under agreed rules is a feasible and effective model for the managed introduction of new treatments to the NHS. |
Downloadable; Printable; Owned
HTML, PDF (66kb)
To purchase this item please login or register.
Complete and print this form to request this document from your librarian